about
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.A second outer-core region in Klebsiella pneumoniae lipopolysaccharideGenetic analysis of the Serratia marcescens N28b O4 antigen gene clusterThe Klebsiella pneumoniae wabG gene: role in biosynthesis of the core lipopolysaccharide and virulence.Virulence Factors of Erwinia amylovora: A ReviewA gene (wbbL) from Serratia marcescens N28b (O4) complements the rfb-50 mutation of Escherichia coli K-12 derivatives.A gene, uge, is essential for Klebsiella pneumoniae virulence.Genetic and structural characterization of the core region of the lipopolysaccharide from Serratia marcescens N28b (serovar O4).Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study)Xyloglucan for the Treatment of Acute Gastroenteritis in Children: Results of a Randomized, Controlled, Clinical TrialA topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study).Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies.Effect of Utipro(®) (containing gelatin-xyloglucan) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study.Usefulness of Housekeeping Genes for the Diagnosis of Helicobacter pylori Infection, Strain Discrimination and Detection of Multiple Infection.Relevant Differences in Perception and Knowledge of Professionals in Different Spanish Autonomous Communities Regarding Availability of Resources for Patients with Dual disorders.Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.Genome Sequence of Plesiomonas shigelloides Strain 302-73 (Serotype O1).Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.The incorporation of glucosamine into enterobacterial core lipopolysaccharide: two enzymatic steps are required.Loading dendritic cells from HIV-1 infected patients with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.Viability qPCR, a new tool for Legionella risk management.Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview.Rhinosectan spray (containing xyloglucan) on the ciliary function of the nasal respiratory epithelium; results of an in vitro studyHealth Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview.Detection of Helicobacter pylori Microevolution and Multiple Infection from Gastric Biopsies by Housekeeping Gene Amplicon Sequencing
P50
Q33466435-C327840B-0227-491D-B512-B028374E1B63Q33468382-19101D0D-4A1B-40E8-BF6F-D8DC27360D5EQ33855535-E38A4623-8EA2-4AB5-BE38-472A89C1FBD9Q33991507-EBFA5783-FFEC-403C-B33B-A1F7708CF4E3Q34232928-EB4B5DF1-CE9A-4CD7-8033-8BDF6CA888B4Q34479913-A85F821F-B05F-4EC3-BC5D-91BAE65C55B5Q35634004-66EA1996-2D8B-48F2-B7D6-871E96F0D77FQ36227608-D22399D6-0138-4F90-8243-B0D12CE3FE3DQ36234154-B7571053-E49B-4372-8CD6-ADE3D7C9CC51Q36719812-F1C01456-B669-456A-97D7-C64F08B69C19Q36885764-043AD065-523E-4849-BEEC-3E6A73C1C76FQ38445599-19C19375-CBDC-4835-9F0E-6AFEDE2DF069Q38739277-12CC2BFA-E1BF-45D8-886D-EAD858F05123Q38888992-E442F889-D048-499D-BEBC-22E1AC423C2DQ39908620-01AF0B7B-B329-4044-B550-F8649E97EE9AQ40893375-70E22458-7782-4AB3-B547-A96BD6211763Q41362133-17B32C0C-B92D-43B2-A1DA-049499967AE7Q41519018-550D5DC1-F8E5-4018-A766-E87B3B665D47Q41731948-A742CCA5-8BA4-4F82-B854-E8A530D8D4E4Q46677498-94CD6241-668F-4B8E-A362-575604226433Q47129619-123F344A-CA7A-4A84-84BE-A952CEC9B89DQ47895995-ED4EE9E7-8A24-40CE-ACA2-7F63054A72EEQ52679056-4E3D8C68-86C2-4E88-90BF-3EF93B85D539Q58579851-6AB1A0BF-3417-44C0-AD43-B73A2078C0ECQ64969076-CFD89A46-6070-4CD3-8A33-1E9F3841AB9FQ89598548-204C6774-5F87-40A5-BA0A-460788542D4C
P50
description
Spaans onderzoekster
@nl
researcher ORCID ID = 0000-0002-7308-030X
@en
spanische Forscherin
@de
name
Núria Piqué
@ast
Núria Piqué
@en
Núria Piqué
@es
Núria Piqué
@ga
Núria Piqué
@nl
Núria Piqué
@sl
type
label
Núria Piqué
@ast
Núria Piqué
@en
Núria Piqué
@es
Núria Piqué
@ga
Núria Piqué
@nl
Núria Piqué
@sl
prefLabel
Núria Piqué
@ast
Núria Piqué
@en
Núria Piqué
@es
Núria Piqué
@ga
Núria Piqué
@nl
Núria Piqué
@sl
P214
P106
P1153
6507631548
P1580
P21
P214
P27
P31
P496
0000-0002-7308-030X
P734
P735
P7859
viaf-305879547